29 September 2023 in Journal of Molecular Medicine
Numerous risk factors for atrial fibrillation (AF) progression have been identified. However, the biomarkers mentioned in the guidelines do not have any clinically relevant predictive value. Some research groups investigated the potential utility of galectin-3 (gal-3) as a diagnostic, prognostic, and predictive biomarker in AF. In this review, we have thoroughly summarized the current data on the role of gal-3 in AF based on the original research in this field. Patients suffering from AF present with increased levels of gal-3. The concentration of gal-3 differs between patients with AF depending on the type of AF — it is higher in patients with persistent AF than in patients with paroxysmal AF. Multiple studies investigating the reappearance of AF in patients who underwent ablation have shown that gal-3 is a promising biomarker to predict the outcome of this therapy. Patients with increased levels of gal-3 are at higher risk of AF recurrence. Although the research considered in this work addressed many aspects of the role of gal-3 in AF, most of it has been conducted on a small group of patients. Therefore, further research and extensive clinical trials confirming described findings are highly warranted.
4 March 2025 in Journal of Education, Health and Sport
Introduction The gut microbiota, a complex community of microorganisms residing in the human gastrointestinal tract, is integral to various bodily functions. Understanding the role of gut microbiota is essential due to its significant influence on human health and disease. Current research indicates that gut microbiota can modulate immune responses and maintain homeostasis. Despite extensive studies, the specific mechanisms by which gut microbiota influences chronic inflammatory diseases remain unclear. Investigating the interaction between gut microbiota and the immune system can provide new insights into potential therapeutic strategies for chronic inflammatory diseases. Aim of the study This study aims to elucidate the mechanisms by which gut microbiota affects immune responses, particularly in chronic inflammatory conditions. We hypothesize that alterations in gut microbiota composition can significantly modulate immune responses, thereby influencing the progression of chronic inflammatory diseases. Conclusions We discuss potential therapeutic interventions targeting the gut microbiota for chronic inflammatory diseases that encompass several approaches. These include the administration of probiotics and prebiotics, fecal microbiota transplantation (FMT), diverse dietary modifications. Personalized microbiome-based therapies offer tailored interventions that combine various methodologies. Further scientific investigation is necessary to comprehensively elucidate and optimize these therapeutic strategies.
11 February 2025 in Quality in Sport
Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts the quality of life of millions worldwide, particularly the elderly. While conventional non-surgical treatments, such as NSAIDs, intra-articular injections, and physical therapy, provide symptomatic relief, their long-term efficacy and safety remain limited. Recent advancements in understanding OA pathophysiology have spurred the development of innovative therapeutic strategies targeting disease progression. This review examines emerging pharmacological and regenerative approaches, including disease-modifying osteoarthritis drugs (DMOADs), biologics, and cell-based therapies. Cutting-edge technologies such as RNA interference, CRISPR/Cas9, and advanced regenerative medicine are also explored for their potential to revolutionize OA management. Additionally, the integration of novel therapies with traditional interventions is discussed, highlighting opportunities for a more personalized, multimodal approach to OA care. Despite significant progress, challenges such as translational hurdles, cost barriers, and long-term efficacy require further investigation. This review emphasizes the transformative potential of emerging therapies in addressing the unmet needs of OA patients and shaping future treatment paradigms.
2 April 2026 in Quality in Sport
Background. Cryotherapy, defined as the therapeutic application of cold, is increasingly used in sports medicine to enhance post-exercise recovery and support athletic performance. The most common modalities include whole-body cryotherapy, local cryotherapy, and cold water immersion. Aim. This article aims to discuss the current evidence on the role of cryotherapy in sports recovery, including its physiological mechanisms, practical applications, benefits, limitations, and impact on training adaptations. Materials and methods. A focused narrative review of relevant literature was conducted to examine the effects of cryotherapy on muscle soreness, fatigue, inflammation, recovery, and athletic performance. Studies on whole-body cryotherapy, local cryotherapy, and cold water immersion were included. Summary. Available evidence suggests that cryotherapy may reduce muscle soreness and perceived fatigue in the short term. However, long-term effects remain inconsistent, and frequent post-exercise cooling may impair muscle adaptation and hypertrophy. The review also highlights the gap between scientific evidence and the commercial promotion of cryotherapy. Conclusions. Cryotherapy may be useful in selected athletic settings, but its application should be individualized and aligned with training goals. Further research is needed to determine optimal protocols and long-term effects on performance.
7 May 2026 in Journal of Education, Health and Sport
Background. Prostate cancer is one of the most common malignancies in men, and its early diagnosis remains challenging due to the lack of specific symptoms in the initial stages. Aim. This review aimed to present current methods used in prostate cancer diagnosis, with emphasis on modern imaging, biomarkers, and artificial intelligence.Materials and methods. A focused narrative review of the relevant literature was conducted, including studies on PSA testing, prostate biopsy, multiparametric MRI, MRI/TRUS fusion biopsy, PSMA PET, molecular biomarkers, and AI-based diagnostic tools.Summary. Traditional methods remain important but have limited specificity. Modern imaging techniques improve lesion detection and biopsy targeting, while biomarkers such as PCA3, PHI, and 4Kscore support risk stratification. AI shows growing potential in imaging and histopathological analysis.Conclusions. An integrated diagnostic approach may improve the detection of clinically significant prostate cancer while reducing unnecessary biopsies, overdiagnosis, and overtreatment.